Page last updated: 2024-12-05

tremorine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5534
CHEMBL ID1483237
CHEBI ID92148
SCHEMBL ID892987
MeSH IDM0021870

Synonyms (46)

Synonym
brn 0006119
nsc 407428
1,4-dipyrrolidine-2-butyne
2-butyne, 1,4-bis(1-pyrrolidinyl)-
pyrrolidine, 1,1'-(2-butyne-1,4-diyl)bis-
pyrrolidine, 1,1'-(2-butynylene)di-
dipyrrolidine, 1,1'-(2-butynylene)-
BRD-K08619838-300-03-2
PRESTWICK3_000331
NCGC00016419-01
cas-300-68-5
BSPBIO_000361
BPBIO1_000399
1,4-dipyrrolidino-2-butyne
51-73-0
nsc-407428
pyrrolidine,1'-(2-butynylene)di-
biofermin
1,4-dipyrrolidinyl-2-butyne
tremorine
nsc407428
tremorin
wln: t5ntj a2uu2- at5ntj
pyrrolidine,1'-(2-butyne-1,4-diyl)bis-
PRESTWICK0_000331
PRESTWICK1_000331
SPBIO_002282
PRESTWICK2_000331
NCGC00016419-02
1-(4-pyrrolidin-1-ylbut-2-ynyl)pyrrolidine
AKOS003662803
5-20-01-00421 (beilstein handbook reference)
unii-u817vz1urq
u817vz1urq ,
SCHEMBL892987
CHEMBL1483237
tremorine [mi]
1,1-(2-butyne-1,4-diyl)bispyrrolidine
JSUAJTLKVREZHV-UHFFFAOYSA-N
1-[4-(1-pyrrolidinyl)-2-butynyl]pyrrolidine #
STL432313
1,1'-but-2-yne-1,4-diyldipyrrolidine
DTXSID00199004
1-[4-(1-pyrrolidinyl)-2-butynyl]pyrrolidine
CHEBI:92148
Q7838182

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Tremorine pretreatment of mice induces tolerance to some effects of oxotremorine. "( Oxotremorine-tolerance: muscarinic blockade or homeostatic adaptation?
György, L, 1979
)
2.32

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic parameters of muscarinic cholinergic drugs after intravenous (IV) and oral administration to mice was determined with ex vivo (3H)-oxotremorine-M (3H-Oxt) binding to the brain."( Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding.
Francis, JW; Sethy, VH, 1990
)
0.7

Dosage Studied

ExcerptRelevanceReference
" FS-32 showed anti-reserpine activity in a dose-dependent manner, whereas imipramine exhibited a bell-shaped dose-response pattern."( Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
Fujimura, Y; Ikeda, Y; Iwasaki, T; Koide, T; Matsushita, H; Nagashima, R; Shindo, M; Shiraki, Y; Suzuki, S; Takano, N, 1979
)
0.26
" Prolonged, 28 days treatment with lysine vasopressin (1 U/kg/day ip) induced hypertension and modified the dose-response curve for tremorine."( The responsiveness of M2-muscarinic receptors in the posterior hypothalamus and brain stem of vasopressin hypertensive rats.
Szadowska, A; Szmigielska, H; Szmigielski, A,
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-alkylpyrrolidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
lethal factor (plasmid)Bacillus anthracis str. A2012Potency5.01190.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency3.54810.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (362)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990353 (97.51)18.7374
1990's5 (1.38)18.2507
2000's2 (0.55)29.6817
2010's1 (0.28)24.3611
2020's1 (0.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.39 (24.57)
Research Supply Index5.95 (2.92)
Research Growth Index4.00 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.52%)5.53%
Reviews2 (0.52%)6.00%
Case Studies1 (0.26%)4.05%
Observational0 (0.00%)0.25%
Other376 (98.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]